Pernix Therapeutics Balance Sheet - Quarterly (NASDAQ:PTX)

Add to My Stocks
$2.45 $0 (0%) PTX stock closing price Jun 15, 2018 (Closing)

A thorough fundamental analysis involves using data from Pernix Therapeutics balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Pernix Therapeutics stock analysis, and provides insights into the firm's financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Pernix Therapeutics had a long term debt of $212.77M at the end of 2018 Q1. To understand the debt servicing capacity of the company, one needs to look at Pernix Therapeutics operating cash flow and Pernix Therapeutics revenue also. Pernix Therapeutics debt to equity ratio is -.

View and download Pernix Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash26.94M32.82M27.24M14.34M22.73M36.37M28.52M29.2M46.64M66.13M
Marketable Securities----------
Receivables37.07M45.44M48.79M45.69M31.68M52.14M48.12M55.47M58.61M67.94M
Inventory5.4M5.39M8.13M8.48M7.44M7.77M8.28M9.69M11.82M10.03M
Raw Materials--1.73M1.87M1.97M2.36M1.5M1.78M1.84M2.04M
Work In Progress--------1.45M1.42M
Finished Goods6.33M5.88M6.87M7.31M6.73M7.39M9.73M11.4M11.98M9.01M
Notes Receivable----------
Other Current Assets7.29M10.11M8.81M13.31M15.06M12.61M13.25M11.65M12.11M13.28M
Total Current Assets
76.71M93.77M92.98M81.83M76.93M108.91M98.18M106.02M129.2M157.39M
Property Plant & Equipment-1.66M---1.8M---2.81M
Accumulated Depreciation----------
Net Property Plant & Equipment
----1.01M1.1M1.19M1.28M2.45M2.34M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles98.9M108.7M145.38M163.53M181.68M200.17M274.5M295.12M317.25M340.8M
Deposits & Other Assets2.11M2.26M2.4M------10.6M
Total Assets
178.4M205.49M241.6M246.48M259.86M310.44M374.16M402.74M449.24M511.15M
Notes Payable3.66M11.1M15.04M-------
Accounts Payable8.79M7.91M22.69M23.09M20.39M7.27M23.13M-37.4M14.08M
Current Portion Long-Term Debt---14M------
Current Portion Capital Leases----------
Accrued Expenses70.06M68.96M58.25M55.73M55.81M75.02M56.35M81.42M62.48M76.36M
Income Taxes Payable----------
Other Current Liabilities8.61M13.26M12.66M16.17M11.24M16.12M11M15.68M21.3M28.65M
Total Current Liabilities
87.47M93.8M93.61M109M87.44M109.52M91.12M100.89M121.19M134.15M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt66.05M65.73M64.87M106.37M105.21M104.07M102.95M101.87M100.81M103.8M
Long-Term Debt212.77M214.24M50.03M173.1M14M14M198M198.2M203.27M209.94M
Non-Current Capital Leases----------
Other Long-Term Liabilities4.53M5.97M176.32M21.71M195.97M196.9M11.92M11.25M15.28M29.95M
Total Liabilities
370.84M379.74M384.85M410.19M402.63M424.5M404.23M412.45M440.63M478.06M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus261.55M261.15M259.79M245.71M245.05M244.3M242.16M240.88M228.3M226.83M
Retained Earnings-454.11M-435.53M-403.11M-409.47M-387.85M-358.39M-272.31M-245.87M-214.73M-188.8M
Treasury Stock-------5.57M5.56M5.54M
Other Liabilities---0.04M-0.05M-0.07M-0.07M-0.01M---
Shareholders Equity-192.44M-174.25M-143.24M-163.71M-142.77M-114.06M-30.06M-9.71M8.61M33.09M
Total Liabilities & Shareholders Equity178.4M205.49M241.6M246.48M259.86M310.44M374.16M402.74M449.24M511.15M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Pernix Therapeutics stock price, and Pernix Therapeutics historical stock prices show the stock price movement over time, and the Pernix Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Pernix Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PTX stock as of 2018 Q1 is $178.4M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PTX stock had total liabilities of $370.84M for the quarter 2018 Q1.

Pernix Therapeutics Balance Sheet - Key Ratios

Current ratio
0.88
Debt to equity ratio
0
Asset turnover ratio
0.59
Receivables turnover
3.46